HomeProductsFAQ BlogWhatsApp Us
Home › Blog › Complete Guide to Depigmentation Therapy for Extensive Vitiligo
Patient Guide

Complete Guide to Depigmentation Therapy for Extensive Vitiligo

Updated August 5, 202610 min readGulfDermaCare

Table of Contents

  1. What Is Depigmentation Therapy?
  2. Repigmentation vs Depigmentation — The Decision
  3. Who Is a Candidate for Depigmentation Therapy?
  4. The Depigmentation Protocol — Step by Step
  5. What to Expect During Treatment
  6. Sun Protection After Depigmentation
  7. Depigmentation Therapy in the GCC Region
📋 Content Review Process: Medical claims on this page are cross-checked against FDA prescribing information, DermNet NZ, and the American Academy of Dermatology. See our Medical References for sources.

What Is Depigmentation Therapy?

Depigmentation therapy is a dermatological treatment for extensive vitiligo — generally defined as vitiligo covering 50% or more of body surface area — in which the remaining normally pigmented skin is deliberately and permanently removed to match the existing white vitiligo patches, creating a uniform overall skin tone. This differs fundamentally from repigmentation therapies (steroids, phototherapy), which instead try to restore color to the affected white patches. Depigmentation is typically considered only after repigmentation has failed or is judged unlikely to succeed given how much of the body is affected. The only FDA-approved agent for depigmentation therapy is monobenzone cream, specifically indicated for this use since 1952. Treatment is applied twice daily and typically takes 9-12 months to achieve complete depigmentation, with results confirmed permanent and stable in clinical follow-up studies extending to 3 years post-treatment.

Repigmentation vs Depigmentation — The Decision

ApproachGoalBest ForPermanenceSuccess Rate
RepigmentationRestore color to white patchesLimited vitiligo (<50%)VariablePartial in many cases
DepigmentationRemove remaining pigment for uniform skinExtensive vitiligo (>50%)PermanentHigh when correctly selected

Most dermatological guidelines recommend attempting repigmentation therapies first. Depigmentation is typically considered when vitiligo is extensive and repigmentation has failed or is unlikely to succeed.

Who Is a Candidate for Depigmentation Therapy?

The following clinical criteria are generally used to identify appropriate candidates:

The Depigmentation Protocol — Step by Step

  1. Dermatologist assessment: Formal diagnosis of extensive vitiligo, documentation of extent, and assessment of suitability for depigmentation therapy
  2. Informed consent: Thorough discussion of permanence, side effects, sun sensitivity, and realistic expectations
  3. Start with 20%: Begin with monobenzone 20% cream applied twice daily to assess skin tolerance
  4. Tolerance assessment: Monitor for 4–8 weeks at 20% before considering progression to 40%
  5. Regular review: Monthly dermatologist appointments to assess progress and manage side effects
  6. Sun protection: SPF 50+ broad-spectrum sunscreen applied daily from first application — permanently after completion
  7. Treatment completion: Full depigmentation typically achieved at 9–12 months

What to Expect During Treatment

Phase 1 — Weeks 1–6: No visible change

Monobenzone is working at the cellular level during this phase. No visible skin changes occur. Some patients experience mild redness or itching — this is normal and manageable.

Phase 2 — Months 2–4: First results

Treated areas begin showing progressive lightening. This is usually the first "before and after" moment patients notice.

Phase 3 — Months 4–9: Main depigmentation phase

The most dramatic and visible results occur during this phase. Treated areas progressively lighten toward the natural white of existing vitiligo patches.

Phase 4 — Months 9–12: Completion

Complete, permanent depigmentation of treated areas is achieved. Clinical study PMC3533321 documented extremely satisfactory results with stability confirmed at 3-year follow-up.

Sun Protection After Depigmentation

This is non-negotiable. After monobenzone treatment, depigmented skin has permanently lost its natural UV protection (melanin). Without daily SPF 50+ sunscreen:

SPF 50+ broad-spectrum sunscreen must be applied daily for life to all depigmented areas. In GCC countries with extreme UV intensity, SPF 70+ is advisable during summer months.

Depigmentation Therapy in the GCC Region

Vitiligo prevalence in GCC countries (Saudi Arabia, UAE, Qatar, Kuwait, Oman, Bahrain) is estimated at 2–3% — significantly above the global average of approximately 1%. This elevated prevalence means dermatologists across the Gulf region have substantial experience with vitiligo management including depigmentation therapy.

GulfDermaCare supplies Monozan® (monobenzone cream 20%, 40%, 60%) to patients across all GCC countries with 3–7 day delivery via UPS and FedEx.

Buy Monobenzone Cream — GulfDermaCare

Iranian Brand (Monozan by Behvazan Pharma) · From $12 · Ships to GCC in 3-7 days · WhatsApp order

Order on WhatsApp

Medical References & Sources

This article is written to align with published dermatological literature and official prescribing information. Primary sources you can review directly:

GulfDermaCare is a pharmaceutical supplier, not the author of these studies — we link to them so you and your dermatologist can review the primary evidence directly.

Frequently Asked Questions

When should depigmentation therapy be considered for vitiligo?
Depigmentation therapy is generally considered when vitiligo covers 50% or more of body surface area and repigmentation therapies have failed to produce a satisfactory result after at least 12 months of appropriate treatment, such as topical steroids, NB-UVB phototherapy, or calcineurin inhibitors. It represents a permanent decision to remove remaining pigmented skin rather than continuing to attempt restoring color to affected patches. Because the outcome is irreversible, most dermatologists recommend thorough counseling before beginning, covering realistic timelines, expected side effects, and the lifelong sun protection commitment that follows successful treatment. This decision works best when the patient fully understands and accepts the permanence involved, rather than viewing it as a trial they might reverse later if unsatisfied with the visual result.
How long does depigmentation therapy take?
Complete depigmentation typically takes nine to twelve months of consistent twice-daily monobenzone application, following a fairly predictable progression. During the first four to six weeks, no visible change occurs since the cream is working at the cellular level, which can be discouraging but is entirely normal. The first visible lightening usually appears between months two and four, followed by the most significant and rapid progress during months four through nine. Using a higher concentration such as 40% or 60% can meaningfully reduce this overall timeline, sometimes by several weeks to a couple of months, though this comes with a tradeoff of increased skin irritation risk and should only be pursued under dermatologist guidance rather than self-directed acceleration.
Is depigmentation therapy reversible?
No, depigmentation therapy using monobenzone is not reversible under any circumstances currently available in dermatology. The treatment works by permanently destroying melanocytes, the specialized cells responsible for producing skin pigment, through a combination of free radical generation and enzymatic inhibition. Once these cells are eliminated, they do not regenerate, meaning the depigmented result remains stable indefinitely rather than gradually returning to the original skin tone over time. This permanence is precisely why the decision to pursue depigmentation requires careful medical counseling beforehand and genuine informed consent from the patient, ensuring they have fully considered the lifelong implications, including permanent sun sensitivity, before committing to treatment that cannot later be undone if they change their mind.
What dermatologist supervision is needed during depigmentation?
Monthly dermatologist appointments are generally recommended throughout the entire depigmentation treatment period, serving several important purposes beyond simply checking progress. These visits allow your dermatologist to assess how quickly and evenly the depigmentation is progressing, manage any side effects such as irritation or unexpected reactions before they become significant problems, and make informed decisions about whether adjusting the monobenzone concentration might be appropriate given your specific response. Regular supervision also provides an opportunity to monitor for rare but more serious adverse reactions, such as exogenous ochronosis, early enough to address them promptly. Patients who maintain consistent dermatologist supervision throughout treatment generally report better overall outcomes and fewer unmanaged complications than those attempting to self-direct the entire process.
Can depigmentation therapy be done at home without a dermatologist?
While monobenzone cream can technically be self-administered topically at home, the overall depigmentation treatment process should always be supervised by a qualified dermatologist rather than undertaken entirely independently. This is particularly important given the irreversible nature of the results, once melanocytes are destroyed, there is no way to reverse the outcome if complications arise or if the patient later reconsiders their decision. A dermatologist can properly assess whether you are an appropriate candidate based on your specific vitiligo extent and treatment history, guide you through correct application technique to minimize side effects, monitor your progress at appropriate intervals, and catch any concerning reactions early. Attempting this treatment entirely without professional guidance significantly increases the risk of both suboptimal results and unmanaged side effects.

Related Pages

HomeProducts Benoquin AlternativeMonozan Cream Saudi ArabiaUAE Shipping PolicyContact What Is Monobenzone Cream?Side Effects Guide FAQAll Articles